DRW Securities’s Edesa Biotech EDSA Stock Holding History

DRW Securities’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-134,222	Closed	-$191K	–	1410
2025 Q4	$191K	Buy	+134,222	New	+$263K	0.01%	984

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

DRW Securities's EDSA Position: Q1 2026 in Review

DRW Securities sold out of Edesa Biotech (EDSA) in Q1 2026, closing a stake of 134,222 shares — an estimated $191K sold.

DRW Securities first reported a position in EDSA in Q4 2025 and held it in 1 quarter. The position peaked at $191K in Q4 2025. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

DRW Securities reported no remaining Edesa Biotech position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 134,222 Edesa Biotech shares in Q1 2026, an estimated $191K.
DRW Securities first reported a position in Edesa Biotech in Q4 2025 and held it in 1 quarter.
DRW Securities's Edesa Biotech position peaked at $191K in Q4 2025.
28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.